PDCD1 and neoplasm: They also examined PD-1 inhibition on ex vivo T-cell response to DC/tumor fusions (“a cancer vaccine in which autologous tumor was fused with dendritic cells, resulting in the presentation of tumor antigens in the context of DC-mediated costimulation”).